Product Center

White Papers

• A Long Term Evaluation of the BDProbeTec™ ET System for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in a High Volume Clinical Laboratory
• A Method to Enumerate Chlamydia trachomatis by Counting DFA Stained Elementary Bodies on a Printed Microscope Slide
• Analytical Reproducibility of the BD Viper™ System with XTR™ Technology (extracted mode) for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae When Using the BD ProbeTec™ CT/GC Q^x Amplified DNA Assays
• Clinical Comparison of the BDProbeTec™ ET Amplified DNA Assay and the Abbott LCx for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Endocervical Swabs and Urine Samples
• Clinical Evaluation of the BD Viper™ System and the BD ProbeTec™ CTQx Amplified DNA Assay (CTQx) for the Direct Qualitative Screening of Chlamydia trachomatis (CT) in Female Endocervical, Female Vaginal, and Female Urine Specimens
• Clinical Evaluation of the BDProbeTec™ ET System in Detecting C. Trachomatis and N. Gonorrhoeae in Endocervical and Female Urine Specimens.
• Comparison of BDProbeTec™ ET, Abbott LCx®, Roche COBAS AMPLICOR®, and GenProbe PACE 2® Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Female Urine and Swab Specimens
• Comparison of the BD ProbeTec ET and Gen Probe PACE 2 Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Endocervical Samples
• Comparison of the BDProbeTec™ ET System to Ligase Chain Reaction (LCR) for the Detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC)
• Comparison of the BDProbeTec™ ET System to Ligase Chain Reaction and Polymerase Chain Reaction for Detection Chlamydia trachomatis and Neisseria gonorrhoeae
• Comparison of Three Nucleic Acid Amplification Tests for the Detection of Chlamydia trachomatis in Urine Specimens
• Comparison of Two Nucleic Acid Amplification Tests to Culture for the Detection of Pharyngeal
• Comparison of Workflow and Analytical Sensitivity with Urine Specimens between the BD ProbeTec™ ET System and the BD Viper™ System in Extracted Mode.
• Compatibility of Accurun^® and Amplichek™ Positive Controls with the BD ProbeTec™ ET CT/GC Amplified DNA Assays
• Correlation of Three Commercial Nucleic Acid Amplification Techniques and Conventional Assys for Chlamydia trachomatis and Neisseria gonorrhoeae in Female Endocervical Swab and Urine Specimens
• Detection of Bordetella pertussis by Homogeneous Strand Displacement Amplification for use on the BDProbeTec™ ET System
• Detection of Chlamydia pneumoniae and Other Organisms of the Chlamydiaceae Family by Strand Displacement Amplification on the BD ProbeTec™ ET System*
• Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Enzyme Immunoassay, Culture, and Three Nucleic Acid Amplification Tests
• Detection of Chlamydia trachomatis and Neisseria gonorrhoeae from Endocervical Swabs: A Comparative Evaluation of Three Commercial Kits
• Detection of Chlamydia trachomatis and Neisseria gonorrhoeae from Vaginal Swabs Using Second Generation Assays on the BD ProbeTec™ ET System
• Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine using the BD ProbeTec™ CT Qx and GC Qx Amplified DNA Assays on the BD Viper™ System in Extracted Mode
• Detection of Chlamydia trachomatis and Neisseria gonorrhoeae on Endocervical and Vaginal Swabs with the BD ProbeTec™ CTQx and GCQx Amplified DNA Assays* on the BD Viper™ System in Extracted Mode*
• Detection of Legionella pneumophila by Strand Displacement Amplification on the BDProbeTec™ ET System
• Detection of Legionella pneumophila, Mycoplasma pneumoniae, and the Chlamydiaceae Family from a Single Throat Swab Using the BD ProbeTec™ ET System
• Detection of Mycoplasma pneumoniae by Strand Displacement Amplification on the BDProbeTec™ ET System
• Detection of Community Acquired Pneumonia Pathogens in Lower Respiratory Specimens Using the BD ProbeTec™ ET System
• Detection of Herpes Simplex Virus Type 1 and Type 2 DNA by Strand Displacement Amplification on the BD ProbeTec™ ET System
• Detection of Herpes Simplex Virus Type 1 by Strand Displacement Amplification on the BD ProbeTec™ ET System
• Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) by Reverse Transcriptase-Strand Displacement Amplification on the BD ProbeTec™ ET System
• Development of a Homogeneous DNA Amplification Test for the Real-Time, Direct Detection of Mycobacterium tuberculosis DNA on the BDProbeTec™ ET Instrument
• Effect of Potentially Interfering Substances on the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Samples Using the BDProbeTec™ ET System
• Endocervical Swab Performance from STD Clinics with the BD ProbeTec™ Chlamydia trachomatis (CT) Q^x Amplified DNA Assay and the BD ProbeTec™ Neisseria gonorrhoeae (GC) Q^x Amplified DNA Assay on the BD Viper™ System with XTR™ Technology (BD Viper System with XTR)
• Evaluation of BDProbeTec™ ET for the Detection of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Female Urogenital Specimens
• Evaluation of Room Temperature Storage and Stability of Specimens in the BDProbeTec™ ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae from Female Endocervical and Female and Male Urine Specimens
• Evaluation of Swab Interfering Substances on the BDProbeTec™ ET Chlamydia trachomatis and Neisseria gonorrhoeae Amplified DNA Assay
• Evaluation of the BD ProbeTec CTQ Amplified DNA Assay for Detection of the New Chlamydia trachomatis Variant in Sweden
• Evaluation of the BD ProbeTec ET System for Chlamydia trachomatis and Neisseria gonorrhoeae Infections of the Endocervix and Oropharynx in Women
• Evaluation of the BD ProbeTec™ Urine Preservative Transport (UPT) for Use With the BD ProbeTec™ ET Neisseria gonorrhoeae Amplified Assays
• Evaluation of the BDProbeTec™ ET Assay for Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae Infections
• Evaluation of the BDProbeTec™ ET Oven to Render Microorganisms Nonviable Prior to Testing on the BDProbeTec™ ET System
• Evaluation of the BDProbeTec™ ET System for N. gonorrhoeae and C. trachomatis Diagnosis Using Urine or Swab Specimens from Females Attending STD Clinics
• Evaluation of the BDProbeTec™ ET System for the Direct Detection of Mycobacterium tuberculosis Complex from Clinical Respiratory Specimens using Strand Displacement Amplification Technology
• Evaluation of the BDProbeTec™ ET System on Urine and Endocervical Specimens for the Identification of Chlamydia and Gonorrhea Infections.
• Evaluation of the BDProbeTec™ ET System on Urine and Genital Specimens for the Identification of Chlamydia and Gonorrhea Infections in Adolescents
• Evaluation of the BDProbeTec™ ET Thermophilic Strand Displacement Assay for the Simultaneous Amplification and Detection of Chlamydia Trachomatis and Neisseria Gonorrhoeae.
• Evaluation of the BDProbeTec™ ET* System for the Direct Detection of Mycobacterium tuberculosis Complex from Smear Negative Respiratory Samples
• Experimental Evaluation of Chlamydia trachomatis and Neisseria gonorrhoeae Detection Sensitivity of BDProbeTec™ ET
• Feasibility of Using TriPath Imaging,^® Inc. SurePath™ Preservative Fluid with the BD ProbeTec™ ET CT/GC Amplified DNA Assays*
• Multicenter Evaluation of the BDProbeTec™ ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens, Female Endocervical Swabs, and Male Urethral Swabs
• Multicenter Evaluation of the BDProbeTec™ ET System in Detecting Chlamydia trachomatis and Neisseria gonorrhoeae from Endocervical and Urine Specimens in Women
• Multicenter Evaluation of the BDProbeTec™ ET System in Detecting Chlamydia trachomatis and Neisseria gonorrhoeae from Endocervical and Urine Specimens in Women
• Performance Comparison of the Becton Dickinson ProbeTec System for Direct Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male and Female Urine Specimens in Comparison With the Roche Cobas System
• Performance of PreservCyt® Solution Specimens on the BD Viper™ System with XTR™ Technology Utilizing the BD ProbeTec™ Chlamydia trachomatis (CT) Q^x Amplified DNA Assay
• Performance of PreservCyt® Solution Specimens on the BD Viper™ System with XTR™ Technology with the BD ProbeTec™ Neisseria gonorrhoeae (GC) Q^x Amplified DNA Assay
• Performance of the BD ProbeTec™ CT Qx and GC Qx Amplified DNA Assays with PreservCyt&red; Specimens on the BD Viper™ System in Extracted Mode
• Performance of the BD ProbeTec™ Urine Preservative Transport with Second Generation Amplified DNA Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae on the BD ProbeTec™ ET System
• Performance of the BD ProbeTec™CT Qx and GC Qx Amplified DNA Assays* with Urine and Vaginal Swab Specimens in the Presence of Potential Interfering Substances
• Performance of the BD Viper™ System in Extracted Mode* with the New BD ProbeTec™ Chlamydia trachomatis and Neisseria gonorrhoeae Qx Amplified DNA Assays*
• Repeatability Evaluation of Specimens Tested with the BD ProbeTec™ CT/GC Q^x Amplified DNA Assays on the BD Viper™ System with XTR Technology
• Strand Displacement Amplification and Homogeneous Real-Time Detection Incorporated in a Second-Generation DNA Probe System, BDProbeTecET
• Strand Displacement Amplification for the Diagnosis of Chlamydia and Gonorrhea in North Queensland
• Take Action on HEDIS
• The Development of Three Strand Displacement Amplification Assays for Culture Confirmation of Mycobacterium tuberculosis Complex, Mycobacterium avium Complex and Mycobacterium kansasii on the BDProbeTec™ ET System
• Time-Motion Comparison of BD ProbeTec™ ET System and Gen-Probe^® APTIMA^® Combo 2™ Assay for Chlamydial and Gonorrhea Diagnosis
• Universal Probes for Homogeneous Real-Time Fluorescent Detection of Strand Displacement Amplification Products
• Validation of the BD ProbeTec™ Urine Preservative Transport (UPT) for use with the BD ProbeTec™ ET System for Detection of Chlamydia Trachomatis
• Work Flow Efficiencies and Operator Advantages Determined for the BD™ Viper ER and the BD™ ProbeTec